Expression and Activation by Epstein Barr Virus of Human Endogenous Retroviruses-W in Blood Cells and Astrocytes: Inference for Multiple Sclerosis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Mameli, Giuseppe ^a   Poddighe, Luciana ^a   Mei, Alessandra ^a   Uleri, Elena ^a   Sotgiu, Stefano ^a   Serra, Caterina ^a   Manetti, Roberto ^a   Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 350; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNCYTIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; ASTROCYTE; B LYMPHOCYTE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ACTIVATION; VIRUS EXPRESSION; VIRUS TRANSCRIPTION;

ADULT; ASTROCYTES; BASE SEQUENCE; BLOOD CELLS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; COMPUTATIONAL BIOLOGY; CYTOKINES; DNA; ENDOGENOUS RETROVIRUSES; FEMALE; GENE PRODUCTS, ENV; GENES, ENV; GENETIC LOCI; GENOME, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUTAGENESIS, INSERTIONAL; PREGNANCY PROTEINS; RNA; VIRUS ACTIVATION; YOUNG ADULT;

HUMAN ENDOGENOUS RETROVIRUS W; HUMAN ENDOGENOUS RETROVIRUSES; HUMAN HERPESVIRUS 4; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRUS;

EID: 84866950155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044991     Document Type: Article

References (89)

1. McQualter JL, Bernard CC, (2007) Multiple sclerosis: a battle between destruction and repair. J Neurochem 100: 295-306.
2. Santiago O, Gutierrez J, Sorlozano A, De Dios Luna J, Villegas E, et al. (2010) Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis 29: 857-866.
3. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, et al. (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 5(9). pii: e12496.
4. Dolei A, (2006) Endogenous retroviruses and human disease. Exp Rev Clin Immunol 2: 149-167.
5. Dolei A, Perron H, (2009) The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol 1: 4-13.
6. Perron H, Lang A, (2010) The Human Endogenous Retrovirus Link between Genes and Environment in Multiple Sclerosis and in Multifactorial Diseases Associating Neuroinflammation. Clinic Rev Allerg Immunol 1: 51-61.
7. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C, (2011) Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophy Acta 2: 162-176.
8. Perron H, Geny C, Laurent A, Mouriquand C, Pellat J, et al. (1989) Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 140: 551-561.
9. Mi S, Lee X, Li X, Veldman GM, Finnerty H, et al. (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789.
10. Firouzi R, Rolland A, Michel M, Jouvin-Marche E, Hauw JJ,et al. (2003) Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol 9: 79-93.
11. Antony JM, Van Marle G, Opii W, Butterfield DA, Mallet F, et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7: 1088-1095.
12. Mameli G, Astone V, Arru G, Marconi S, Lovato L, et al. (2007a) Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J Gen Virol 88: 264-274.
13. Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, et al. (2005) Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol 11: 23-33.
14. Arru G, Mameli G, Astone V, Serra C, Huang YM, et al. (2007) Multiple sclerosis and HERV-W/MSRV: a multicentric study. Int J Biomed Sci 3: 292-297.
15. Dolei A, Serra C, Mameli G, Pugliatti M, Sechi S, et al. (2002) Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58: 471-473.
16. Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, et al. (2002) Multiple sclerosis (MS)-associated retrovirus and MS prognosis: an observational study. Neurology 59: 1071-1073.
17. Sotgiu S, Arru G, Mameli G, Serra C, Pugliatti M, et al. (2006) MSRV in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Mult Scler 12: 698-703.
18. Sotgiu S, Mameli G, Serra C, Zarbo IR, Arru G, et al. (2010) Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler 16: 1248-1251.
19. Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, et al. (2008) Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol 1: 73-77.
20. Sotgiu S, Arru G, Söderström M, Mameli G, Serra C, et al. (2006) MSRV and optic neuritis. Mult Scler 12: 357-359.
21. Petersen T, Møller-Larsen A, Thiel S, Brudek T, Hansen TK, et al. (2009) Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. J Neuroimmunol 215: 108-116.
22. Ascherio A, Munger KL, (2010) Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 3: 271-277.
23. Munger K, Levin L, O'Reilly E, Falk K, Ascherio A, (2011) Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17: 1185-1193.
24. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D, (2004) Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 58: 1032-1035.
25. Lucas RM, Hughes AM, Lay ML, Ponsonby AL, Dwyer DE, et al. (2011) Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 82: 1142-1148.
26. Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, et al. (2009) Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler 15: 431-436.
27. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, et al. (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 9: 773-781.
28. Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, et al. (2010) Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2: 159-169.
29. Fatima N, Toscano MP, Hunter SB, Cohen C, (2011) Controversial role of Epstein-Barr virus in multiple sclerosis. Appl Immunohistochem Mol Morphol 3: 246-252.
30. Ludwin S, Jacobson S, (2011) Epstein-Barr Virus and MS: Causality or Association? Int MS J 17: 39-43.
31. Giovannoni G, (2011) Epstein-Barr Virus and MS. Int MS J 17: 44-49.
32. Pavlicek A, Paces J, Elleder D, Hejnar J, (2002) Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res 12: 391-399.
33. Li F, Nellåker C, Yolken RH, Karlsson H, (2011) A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC Genomics 12: 22.
34. Mameli G, Poddighe L, Astone V, Delogu G, Arru G, et al. (2009) Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods 161: 98-106.
35. Garson JA, Huggett JF, Bustin SA, Pfaffl MW, Benes V, et al. (2009) Unreliable real-time PCR analysis of human endogenous retrovirus-W (HERV-W) RNA expression and DNA copy number in multiple sclerosis. AIDS Res Hum Retroviruses 25: 377-378.
36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
37. Menet A, Speth C, Larcher C, Prodinger WM, Schwendinger MG, et al. (1999) Epstein-Barr virus infection of human astrocyte cell lines. J Virol 73: 7722-7733.
38. Gasque P, Chan P, Mauger C, Schouft MT, Singhrao S, et al. (1996) Identification and characterization of complement C3 receptors on human astrocytes. J Immunol 156: 2247-2255.
39. Sugano N, Chen W, Roberts ML, Cooper NR, (1997) Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction. J Exp Med 186: 731-737.
40. Mameli G, Astone V, Khalili K, Serra C, Sawaya BE, et al. (2007b) Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362: 120-130.
41. Ifergan I, Kébir H, Bernard M K, Wosik A, Dodelet-Devillers R, et al. (2008) The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131: 785-99.
42. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, et al. (2009) Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132: 3318-3328.
43. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, et al. (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204: 2899-2912.
44. Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM, (2011) NeuroproMiSe EBV Working Group (2011) Epstein-Barr virus in the multiple sclerosis brain: a controversial issue - report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 134: 2772-2786.
45. De Villiers JN, Treurnicht FK, Warnich L, Carr J, van Rensburg SJ, et al. (2006) Analysis of viral and genetic factors in South African patients with multiple sclerosis. Metab Brain Dis 21: 163-169.
46. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H, (1998) Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351: 33.
47. Nowak J, Januszkiewicz D, Pernak M, Liwen I, Zawada M, et al. (2003) Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients. J Neurovirol 9: 112-117.
48. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, et al. (1997) The Collaborative Research Group on Multiple Sclerosis: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 94: 7583-7588.
49. Serra C, Sotgiu S, Mameli G, Pugliatti M, Rosati G, et al. (2001) Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci 22: 171-173.
50. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, et al. (2001) Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 50: 434-442.
51. Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, et al. (2009) B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 6: 104.
52. Perron H, Suh M, Lalande B, Gratacap B, Laurent A, et al. (1993) Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 74: 65-72.
53. Lee WJ, Kwun HJ, Kim HS, Jang KL, (2003) Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 15: 75-80.
54. Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, et al. (2006) Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol 12: 65-71.
55. Nellåker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, et al. (2006) Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 3: 44.
56. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT, (2001) Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15: 579-589.
57. Sutkowski N, Chen G, Calderon G, Huber BT, (2004) Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 78: 7852-7860.
58. Hsiao FC, Lin M, Tai A, Chen G, Huber BT, (2006) Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol 4: 2056-2060.
59. Hsiao FC, Tai AK, Deglon A, Sutkowski N, Longnecker R, et al. (2009) EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology 1: 261-266.
60. Turcanova VL, Bundgaard B, Höllsberg P, (2009) Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J Clin Virol 46: 15-19.
61. Tai AK, Luka J, Ablashi D, Huber BT, (2009) HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 46: 47-48.
62. Williams A, Piaton G, Lubetzki C, (2007) Astrocytes-friends or foes in multiple sclerosis? Glia 55: 1300-1312.
63. Bhat RK, Ellestad KK, Wheatley BM, Warren R, Holt RA, et al. (2011) Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PLoS One 6: e19176.
64. Roebke C, Wahl S, Laufer G, Stadelmann C, Sauter M, et al. (2010) A N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3. Retrovirology 7: 69.
65. De Parseval N, Lazar V, Casella JF, Benit L, Heidmann T, (2003) Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J Virol 77: 10414-10422.
66. Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, et al. (1999) Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260: 1-9.
67. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, et al. (1997) The Collaborative Research Group on Multiple Sclerosis: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 94: 7583-7588.
68. Perron H, Perin JP, Rieger F, Alliel PM, (2000) Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis? J NeuroVirol 6: S67-S75.
69. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, et al. (2003) In vitro modulation of the multiple sclerosis (MS)-associated retrovirus (MSRV) by cytokines: implications for MS pathogenesis. J NeuroVirol 9: 637-643.
70. Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K, (2009) Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences. Retrovirology 6: 37.
71. Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, et al. (2007) The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J Immunol 179: 1210-1224.
72. Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, et al. (2007) Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 82: 1212-1220.
73. Morandi B, Bramanti P, Bonaccorsi I, Montalto E, Oliveri D, et al. (2008) Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol Res 57: 1-5.
74. Mendes A, Sá MJ, (2011) Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works. Arq Neuropsiquiatr 69: 536-543.
75. Kim DY, Hong GU, Ro JY, (2011) Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation 8: 25.
76. Lavillette D, Marin M, Ruggieri A, Mallet F, Cosset FL, et al. (2002) The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol 76: 6442-6452.
77. Weis S, Llenos IC, Dulay JR, Verma N, Sabunciyan S, et al. (2007) Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression. J Neural Transm 114: 261-271.
78. Constantino AA, Huang Y, Zhang H, Wood C, Zheng JC, (2011) HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity. Neurotox Res 20: 277-88.
79. Yadav A, Collman RG, (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4: 430-447.
80. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, et al. (2011) Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol 122: 601-614.
81. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, et al. (2006) The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 176: 7636-7644.
82. Huynh GT, Adler FR (2011) Mathematical modelling the age dependence of Epstein-Barr virus associated infectious mononucleosis. Math Med Biol.
83. McDonald WI, Compston A, Edan G, Goodkin DHP, Hartung A, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50: 121-127.
84. D'Addario M, Ahmad A, Morgan A, Menezes J, (2000) Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases. J Mol Biol. 2000 May 19 298(5): 765-78.
85. Serra C, Biolchini A, Mei A, Kotenko S, Dolei A, (2008) Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4. AIDS Res Hum Retroviruses 24: 173-80.
86. Surabhi RM, Gaynor RB, (2002) RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication. J Virol 76: 12963-12973.
87. Annunziato F, Romagnani P, Cosmi L, Beltrame C, Steiner BH, et al. (2001) Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection. J Immunol 22: 238-246.
88. Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, et al. (2006) Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol 12: 65-71.
89. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, et al. (2012) Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. 2012 Mar 30. [Epub ahead of print] doi: 10.1177/1352458512441381.